Form D · Other Health Care
Cardiosolv Ablation Technologies Inc.
Baltimore, MD · CIK 0001698904
Offering snapshot reported Feb 24, 2017 · SEC filing
- Reported sold
- $52K Offering amount: $100K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 10, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 24, 2017 | Initial | $52,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-281274
Source: Form D, filed Feb 24, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven Girouard | Director |
| Scott Kokones | Director, Executive |
| Steven Laporte | Director |
| Vincent Owens | Director, Executive |
| Brock Tice | Director |
| Natalia Trayanova | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2443 Maryland Avenue
Baltimore, MD, 21218
Baltimore, MD, 21218